39th Annual Meeting of the American College of Clinical Pharmacology

m Bookmark and Share


The 39th Annual Meeting of the American College of Clinical Pharmacology is beeing held September 12-14, 2010 at the Baltimore Marriott Waterfront in Baltimore, Maryland.

The Meeting includes a wide range of exciting topics such as pharmacometrics, pharmacogenomics, international drug development and collaboration, and specific sessions concerning biologics, nutraceuticals, and drug therapy in special populations. New this year, the educational sessions offer a series of concurrent symposia that are timely and encourage audience interaction, while critically challenging current practices and outcomes for future directions. Join colleagues from around the world and participate in the ACCP’s exceptional learning and networking opportunities.

  • Keynote Speaker Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of the U.S. Food and Drug Administration, will address the audience on Tuesday with his presentation “Pharmacology and Public Health at FDA”.
  • Keynote Speaker Stephen P. Spielberg, M.D., Ph.D., Director, Center for Personalized Medicine & Therapeutic Innovation, will present his address “What the ‘developed’ and ‘developing’ worlds have taught each other about health and therapeutics for children” on Monday morning.
  • CME and CPE credits are available for registered attendees.
Learn more: www.accp1.org/accp_annual_meeting

Contact: Mina Behari, 3 Ellinwood Court, New Hartford, NY 13413-1105
Telephone: (315) 768-6117 Fax: (315) 768-6119
E-mail: mina@accp1.org Website: www.accp1.org